Matthew Locke is a Principal Scientist in Non-Malignant Hematology at Roche, having previously served as a Senior Scientist at the same company from 2021 to 2023, focusing on coagulation biology and bleeding disorders R&D. Prior to joining Roche, Matthew held roles at the Medicines and Healthcare products Regulatory Agency as a Senior Scientist, where they led projects to establish WHO International Standards, and at Barts Cancer Institute as a Postdoctoral Research Fellow, developing drug repurposing screens for cancer treatments. Matthew's educational background includes a D.Phil in Pharmacology and a Master of Biochemistry from the University of Oxford.
Location
Basel, Switzerland
This person is not in the org chart
This person is not in any teams
This person is not in any offices